共 50 条
- [41] Lenalidomide, bortezomib, and dexamethasone (Rev/Vel/Dex) in patients with relapsed or relapsed/refractory multiple myeloma (MM): Preliminary results of a phase II studyBLOOD, 2007, 110 (11) : 797A - 797ARichardson, PaulJagannath, SundafRaje, NoopurJakubowiak, AndrzejLonial, SagarGhobrial, IreneSchlossman, RobertMazumder, AmitabhaMunshi, NikhilColson, KathleenMcKenney, MaryFarrell, MelissaLunde, LauraGiove, LawrenceKaster, SarahMitsiades, ConstantineHideshima, TeruKnight, RobertEsseltine, Dixie-LeeAnderson, Kenneth
- [42] Phase Ib Study of Panobinostat and Bortezomib in Relapsed or Relapsed and Refractory Multiple MyelomaJOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (29) : 3696 - +San-Miguel, Jesus F.Richardson, Paul G.Guenther, AndreasSezer, OrhanSiegel, DavidBlade, JoanLeBlanc, RichardSutherland, HeatherSopala, MonikaMishra, Kaushal K.Mu, SongBourquelot, Priscille M.Victoria Mateos, MariaAnderson, Kenneth C.
- [43] Phase I/II study of bortezomib in combination with liposomal doxorubicin and melphalan in relapsed or refractory multiple myeloma.BLOOD, 2005, 106 (11) : 379B - 379BChari, AKaplan, LLinker, CDamon, LENavarro, WHMartin, T
- [44] Tanespimycin (T) plus bortezomib (BZ) in multiple myeloma (MM): Pharmacology, safety and activity in relapsed/refractory (rel/ref) patients (Pts)JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)Richardson, P. G.Chanan-Khan, A.Lonial, S.Krishnan, A.Carroll, M.Cropp, G. F.Albitar, M.Johnson, R. G.Hannah, A.Anderson, K.
- [45] Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myelomaCANCER, 2016, 122 (13) : 2050 - 2056Orlowski, Robert Z.Nagler, ArnonSonneveld, PieterBlade, JoanHajek, RomanSpencer, AndrewRobak, TadeuszDmoszynska, AnnaHorvath, NoemiSpicka, IvanSutherland, Heather J.Suvorov, Alexander N.Xiu, LiangCakana, AndrewParekh, TrilokSan-Miguel, Jesus F.
- [46] Bortezomib in relapsed or refractory multiple myeloma:: results in a cohort of 39 patientsREVISTA CLINICA ESPANOLA, 2008, 208 (04): : 187 - 192Canovas Fernandez, A.Alonso Alonso, J. J.Barreiro Garcia, J. G.Aguirre Errasti, C.
- [47] Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple MyelomaJOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (34) : 5713 - 5719Richardson, Paul G.Weller, EdieJagannath, SundarAvigan, David E.Alsina, MelissaSchlossman, Robert L.Mazumder, AmitabhaMunshi, Nikhil C.Ghobrial, Irene M.Doss, DeborahWarren, Diane L.Lunde, Laura E.McKenney, MaryDelaney, CarolMitsiades, Constantine S.Hideshima, TeruDalton, WilliamKnight, RobertEsseltine, Dixie-LeeAnderson, Kenneth C.
- [48] PANORAMA 2: A PHASE II STUDY OF PANOBINOSTAT IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED AND BORTEZOMIB-REFRACTORY MULTIPLE MYELOMAHAEMATOLOGICA, 2012, 97 : 338 - 338Richardson, P.Alsina, M.Weber, D.Coutre, S.Lonial, S.Gasparetto, C.Warsi, G.Ondovik, M.Mukhopadhyay, S.Paley, C.Schlossman, R.
- [49] A Phase II Trial of Chloroquine in Combination with Bortezomib and Cyclophosphamide in Patients with Relapsed and Refractory Multiple MyelomaBLOOD, 2014, 124 (21)Montanari, FrancescaLu, MeinaMarcus, SaraSaran, AnkeetaMalankar, AdityaMazumder, Amitabha
- [50] Final Phase I Results of Perifosine In Combination with Lenalidomide and Dexamethasone In Patients with Relapsed or Refractory Multiple Myeloma (MM)BLOOD, 2010, 116 (21) : 1264 - 1264Jakubowiak, Andrzej J.Richardson, Paul G.Zimmerman, Todd M.Alsina, MelissaKaufman, Jonathan L.Kandarpa, MalathiHarvey, Colleen K.Colson, KathleenMitchell, MonicaHideshima, TeruSportelli, PeterGardner, LesaGiusti, KathyAnderson, Kenneth C.